Allogenic CAR T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Galetto, Roman [1 ]
Lebuhotel, Celine [1 ]
Francon, Patricia [1 ]
Gouble, Agnes [1 ]
Smith, Julianne [1 ]
机构：
[1] Cellectis, Paris, France
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)34028-X
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
419
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [21] Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
    Ji, Rui-Jin
    Cao, Guo-Hua
    Zhao, Wei-Qiang
    Wang, Mu-Yao
    Gao, Pan
    Zhang, Yi-Zhou
    Wang, Xue-Bin
    Qiu, Hou-Yuan
    Chen, Di-Di
    Tong, Xiao-Han
    Duan, Min
    Yin, Hao
    Zhang, Ying
    CELL STEM CELL, 2024, 31 (11)
  • [22] CD123 redirected multiple virus-specific T cells for acute myeloid leukemia
    Zhou, Li
    Liu, Xin
    Wang, Xingbing
    Sun, Zimin
    Song, Xiao-Tong
    LEUKEMIA RESEARCH, 2016, 41 : 76 - 84
  • [23] T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
    Mardiros, Armen
    Forman, Stephen J.
    Budde, Lihua E.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 484 - 488
  • [24] CD123 DIAGNOSTIC UTILITY IN ACUTE MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA
    Yang, Wayne
    Loriaux, Marc
    Gatter, Ken
    Braziel, Rita
    Huang, James
    Kelemen, Katalin
    Fan, Guang
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 376 - 376
  • [25] Adoptive Immunotherapy beyond CAR T-Cells
    Titov, Aleksei
    Zmievskaya, Ekaterina
    Ganeeva, Irina
    Valiullina, Aygul
    Petukhov, Alexey
    Rakhmatullina, Aygul
    Miftakhova, Regina
    Fainshtein, Michael
    Rizvanov, Albert
    Bulatov, Emil
    CANCERS, 2021, 13 (04) : 1 - 23
  • [26] Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia
    Sanchez Martinez, Diego
    Tirado, Nestor
    Mensurado, Sofia
    Martinez-Moreno, Alba
    Romecin, Paola
    Aguera, Francisco Gutierrez
    Correia, Daniel, V
    Silva-Santos, Bruno
    Menendez, Pablo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [27] More than a bridging therapy: Targeting CD123 with rapidly switchable universal CAR-T cells for treatment of acute leukemia
    Loff, Simon
    Meyer, Jan-Erik
    Spehr, Johannes
    Riewaldt, Julia
    Gruender, Cordula
    Schreiber, Maria
    Bachmann, Michael
    Pehl, Michael
    Ehninger, Gerhard
    Ehninger, Armin
    Cartellieri, Marc
    CANCER RESEARCH, 2020, 80 (16)
  • [28] SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells
    Wang, Meng
    Wu, Haibin
    Duan, Mingyue
    Yang, Ying
    Wang, Guoxia
    Che, Fengyu
    Liu, Bailing
    He, Wei
    Li, Qiao
    Zhang, Liyu
    LIFE SCIENCES, 2019, 232
  • [29] Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T Cells
    Bhagwat, Anand S.
    Torres, Leonel
    Shestova, Olga
    Shestov, Maksim
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Luger, Selina M.
    Loren, Alison W.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander
    Stadtmauer, Edward A.
    Mangan, James K.
    Brogdon, Jennifer
    Fraietta, Joseph A.
    Hwang, Wei-Ting
    Siegel, Don L.
    Kenderian, Saad S.
    Porter, David L.
    June, Carl
    Gill, Saar
    BLOOD, 2023, 142
  • [30] DEVELOPMENT OF A NOVEL CHIMERIC RECEPTOR SPECIFIC FOR THE CD123 ANTIGEN FOR THE TARGETING OF ACUTE MYELOID LEUKAEMIA (AML)
    Tettamanti, S.
    Marin, V.
    Pizzitola, I.
    Magnani, C. F.
    Attianese, G. M. P. Giordano
    Cribioli, E.
    Maltese, F.
    Galimberti, S.
    Lopez, A.
    Biondi, A.
    Bonnet, D.
    Biagi, E.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 154 - 154
12345